China, Nov. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Extended Letermovir Prophylaxis for High-Risk Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Clinical Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136579
Registration Time: 2026/11/12
Type: Interventional study
Primary Sponsor: Peking University People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348860
Published by HT Digital Content Services with permission from Health Daily Digest....